The findings suggest AI systems can be trained to detect and grade cancer in prostate needle biopsy samples with an accuracy rate equal to that of prostate pathology experts.
Healthcare providers will increasingly be seeking innovative technology as they develop new patient engagement and experience strategies to remain competitive.
While Americans think consumer tech is driving more connected relationships with their providers, they also see voice technology and AI with a skeptical eye.
A study published in Nature suggests its model was able to spot cancer in de-identified screening mammograms with fewer false positives and false negatives than experts.
As artificial intelligence and robotic process automation are more widely deployed, they will help rehumanize medicine by allowing doctors to focus less on paperwork and administrative functions, and more on patient care.